Revelation Biosciences In... (REVBW)

AI Score

Unlock

0.01

-0.00 (-33.33%)

At close: Apr 14, 2025, 3:58 PM

Revelation Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Cash & Equivalents	6.5M	6.54M	12.07M	14.55M	11.99M	13.99M	15.71M	17.7M	5.25M	6.2M	3.48M	7.19M	1.27M	4.14M	6.37M	73.51M	4.49M	3.32M
Short-Term Investments	6.49B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	19.75K	301.72K	390.65K	525.29K	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	48.3M	73.52M	73.51M	73.51M	n/a	n/a
Other Long-Term Assets	56.28M	n/a	n/a	n/a	71.13K	0.00	-0.00	-0.00	n/a	0.00	-0.00	n/a	-48.3M	-73.52M	-187.62K	n/a	73.51M	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	66.7M	74.85K	125.74K	71.88K	100.61K	81.39K	107.51K	118.64K	160.3K	309.63K	575.48K	684.78K	148.73K	n/a	n/a	n/a	128K	177.75K
Total Current Assets	6.57B	6.66M	12.2M	14.62M	12.08M	14.15M	15.96M	18.04M	5.41M	6.51M	4.05M	7.87M	1.91M	5.7M	373.64K	515.16K	4.62M	3.5M
Property-Plant & Equipment	56.33K	81.24K	70.77K	77.99K	65.08K	71.35K	77.61K	83.87K	90.13K	96.39K	102.66K	108.92K	130.14K	167.2K	187.62K	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	56.33M	81.24K	70.77K	77.99K	136.22K	71.35K	77.61K	83.87K	90.13K	96.39K	102.66K	108.92K	130.14K	167.2K	73.51M	73.51M	73.51M	n/a
Total Assets	6.62B	6.74M	12.27M	14.7M	12.21M	14.22M	16.04M	18.12M	5.5M	6.6M	4.15M	7.98M	2.04M	5.87M	73.89M	74.03M	4.62M	3.5M
Account Payables	783.62K	3.13M	1.28M	1.68M	1.36M	1.26M	913.87K	705.09K	554.21K	466.08K	916.48K	1.46M	596.26K	1.03M	907.05K	n/a	865.9K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	2.91M	n/a	n/a	2.91M	n/a	n/a	n/a	-2.59M	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.13M	4.8K	9.39M	3.3M	3.44M	3.64M	3.38M	6.69M	3.28M	3.23M	4.1M	5.64M	n/a	n/a	2.41M	2.12M	342.88K	336.25K
Total Current Liabilities	1.91M	4.07M	11.13M	5.23M	5.56M	5.4M	4.62M	8.1M	4.45M	4.37M	6M	8.08M	2.14M	2.21M	3.31M	2.12M	1.21M	336.25K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.91M	n/a	2.91M	2.91M	n/a	3.15M
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	705.09K	554.21K	466.08K	916.48K	1.46M	2.91M	1.06M	2.91M	2.91M	2.91M	3.15M
Total Liabilities	1.91B	4.07M	11.13M	5.23M	5.56M	5.4M	4.62M	8.1M	4.45M	4.37M	6M	8.08M	2.14M	2.21M	6.22M	5.03M	1.21M	3.49M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16.75K	33.02K	n/a	n/a	n/a	n/a
Common Stock	522.00	4.29K	1.64K	1.63K	265.00	6.3K	6.3K	4.73K	683.00	23.54K	15.08K	15.08K	2.31K	2.31K	73.51M	73.51M	2.29K	2.16K
Retained Earnings	-40.51B	-38.78M	-36.54M	-28.15M	-25.47M	-23.26M	-20.64M	-19.19M	-25.35M	-24.14M	-22.97M	-21.13M	-14.52M	-10.66M	-5.85M	-4.52M	-2.53M	-12.19K
Comprehensive Income	n/a	n/a	n/a	n/a	-0.00	0.00	n/a	-0.00	n/a	n/a	n/a	n/a	62.22M	n/a	0.00	n/a	n/a	n/a
Shareholders Equity	4.71B	2.67M	1.14M	9.47M	6.65M	8.82M	11.41M	10.02M	1.05M	2.23M	-1.84M	-98.51K	-99.47K	3.66M	67.66M	69M	3.41M	12.81K
Total Investments	6.49B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	48.3M	73.54M	73.82M	73.9M	525.29K	n/a